Realkredit Danmark A/S
20.2.2026 09:23:30 CET | Globenewswire | Press release
Drawing rates for bonds issued by Realkredit Danmark A/S
Drawing rates for bonds issued by Realkredit Danmark A/S
| To Nasdaq Copenhagen A/S | Executive Managemet Bernstorffsgade 40 DK-1577 København V www.rd.dk Tel. +45 70 12 53 00 20 February 2026 |
Company announcement No. 13/2026
Drawing rates for bonds issued by Realkredit Danmark A/S
Pursuant to §24 of the Capital Markets Act, Realkredit Danmark A/S hereby publishes drawing rates as of 20 February 2026 for the following payment dates.
01 April 2026 (bonds with four annual settling periods), and
01 July 2026 (bonds with two annual settling periods).
Please find the data in the attached file.
The information will also be available on www.rd.dk.
Please note that DK0004616950 appears on the attached list even though the publication date has been changed to 27 March 2026 due to a negative coupon. It means, that
- The withdrawal amount is fixed, but the negative coupon will be set off against the amount withdrawn before payment to the investor
- If the withdrawal amount is not sufficient to cover the payment of the negative coupon, an additional withdrawal will be made on the basis of market price (without payment) corresponding to the remaining amount
- No preliminary drawing rate will be calculated in the above ISIN until the publication date
Yours faithfully,
The Executive Management
Any additional questions should be addressed to Hella Gebhardt Rønnebæk, Chief Analyst, phone +45 4513 2068.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
2026 China International Fair for Trade in Services (CIFTIS)25.8.2026 17:10:17 CEST | Press release
Overseas session of 2026 CIFTIS held in Kristiansund, Norway
Volta Finance Limited25.8.2026 16:46:13 CEST | Press release
Volta Finance Limited Net Asset Value(s) as at 31 July 2026
Zymeworks Inc.25.8.2026 16:23:13 CEST | Press release
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
ZenaTech Inc.25.8.2026 16:14:32 CEST | Press release
Update - ZenaTech Completes Acquisition of ESM Software, Adding Strategy Execution and Compliance Software to its Enterprise SaaS Division, with Revenue from Government, Healthcare and Financial Services Customers
Talkdesk, Inc25.8.2026 15:30:00 CEST | Press release
Companies are deploying AI in customer experience faster than they can make it work
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom